T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope

被引:63
作者
Hombach, A
Heuser, C
Sircar, R
Tillmann, T
Diehl, V
Kruis, W
Pohl, C
Abken, H
机构
[1] UNIV COLOGNE,INNERE MED KLIN 1,D-50924 COLOGNE,GERMANY
[2] EVANGEL KRANKENHAUS KOLN,COLOGNE,GERMANY
关键词
D O I
10.1053/gast.1997.v113.pm9322511
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Chimeric receptors with specificity for defined tumor antigens are valuable tools for targeting cytolytic T cells specifically to tumor cells, The aim of this study, for the situation of gastrointestinal cancer, was to investigate the generation of a chimeric T cell receptor that specifically binds the tumor antigen TAG72 (CA72-4) and transmits a signal for cellular activation, Methods: A single-chain antibody (scFv) was derived from the monoclonal anti-TAG72 antibody B72.3 by phage display techniques (B72.3-scFv) and fused to the signaling unit of the Fc epsilon-RI receptor gamma chain, resulting in a chimeric signaling receptor, B72.3-scFv-gamma, Results: The B72.3-scFv and the chimeric B72.3-scFv-gamma receptor bound specifically to the TAG72 antigen, After transfection, T cells expressing the chimeric B72.3-scFv-gamma specifically recognized TAG72 positive cells, Cross-linking of the chimeric receptor with antigen resulted in interleukin 2 release and cytolytic activity against TAG72 positive tumor cells in vitro. Conclusions: T cells equipped with the chimeric anti-TAG72 receptor can be specifically activated to target and lyse TAG72 positive gastrointestinal tumor cells.
引用
收藏
页码:1163 / 1170
页数:8
相关论文
共 44 条
[1]   Chimeric T-cell receptors: Highly specific tools to target cytotoxic T-lymphocytes to tumour cells [J].
Abken, H ;
Hombach, A ;
Heuser, C ;
Sircar, R ;
Pohl, C ;
Reinhold, U .
CANCER TREATMENT REVIEWS, 1997, 23 (02) :97-112
[2]  
BATEMAN WJ, 1995, CANCER IMMUNOL IMMUN, V41, P61, DOI 10.1007/BF01788961
[3]   FLUORESCENT EUROPIUM CHELATES AS TARGET-CELL MARKERS IN THE ASSESSMENT OF NATURAL-KILLER-CELL CYTOTOXICITY [J].
BLOMBERG, K ;
ULFSTEDT, AC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 160 (01) :27-34
[4]   T-CELL TARGETING IN CANCER-THERAPY [J].
BOLHUIS, RLH ;
STURM, E ;
BRAAKMAN, E .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 34 (01) :1-8
[5]   MAKING ANTIBODY FRAGMENTS USING PHAGE DISPLAY LIBRARIES [J].
CLACKSON, T ;
HOOGENBOOM, HR ;
GRIFFITHS, AD ;
WINTER, G .
NATURE, 1991, 352 (6336) :624-628
[6]   In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes - Results of a double gene marking trial [J].
Economou, JS ;
Belldegrun, AS ;
Glaspy, J ;
Toloza, EM ;
Figlin, R ;
Hobbs, J ;
Meldon, N ;
Kaboo, R ;
Tso, CL ;
Miller, A ;
Lau, R ;
McBride, W ;
Moen, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :515-521
[7]   SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS [J].
ESHHAR, Z ;
WAKS, T ;
GROSS, G ;
SCHINDLER, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :720-724
[8]  
FINER MH, 1994, BLOOD, V83, P43
[9]   ANTITUMOR MONOCLONAL-ANTIBODIES GENERATED BY IMMUNIZATION WITH MUCINS [J].
GILLETTE, RW ;
SINGLETON, J ;
GUILLEN, D ;
GILMAN, SC .
HYBRIDOMA, 1991, 10 (05) :583-594
[10]   MONOCLONAL-ANTIBODY B72.3 REACTS WITH A CORE REGION STRUCTURE OF O-LINKED CARBOHYDRATES [J].
GOLD, DV ;
MATTES, MJ .
TUMOR BIOLOGY, 1988, 9 (2-3) :137-144